06:32 PM EST - Stellar Biotechnologies, Inc. : announced that its California subsidiary has been awarded two grants under the Therapeutic Discovery Project Program for a total grant award of $488,985. The grants are for "Diagnostic Immune Status Monitoring in Patients with Immunodeficiency" and "Enabling ICH-S8 Immunotoxicity Testing with Keyhole Limpet Hemocyanin." The awards are granted immediately and provide supplemental funding for the Company's diagnostic development and Stellar KLH/IMG platforms. Stellar Biotechnologies, Inc.
shares V.KLH are trading up $.10 at $0.94.
